Skip to content Skip to footer

Inside neffy’s Launch Strategy: A Stimulating Conversation with Richard Lowenthal, CEO & Co-Founder of ARS Pharmaceuticals 

Shots: Inconsistent access to epinephrine auto-injectors continues to be a major unmet need in the management of anaphylaxis neffy, an innovative intranasal epinephrine spray, provides a needle-free alternative for the emergency treatment of severe allergic reactions, including anaphylaxis, in adults and children aged four years and older who weigh at least 33 lbs Richard Lowenthal,…

Read more